Annovis Bio, Inc. (ANVS) Misses Q3 EPS by 46c

Annovis Bio, Inc. (NYSE: ANVS) reported Q3 EPS of ($0.97), $0.46 worse than the analyst estimate of ($0.51).

For earnings history and earnings-related data on Annovis Bio, Inc. (ANVS) click here.

You May Also Be Interested In

• Fed’s Waller open to September rate hold - if disinflation holds up
• Duluth Holdings Inc. (DLTH) Tops Q2 EPS by 49c
• Campbell Soup (CPB) Reports In-Line Q4 EPS, Misses on Revenue; Offers FY27 EPS Guidance